Our observed DNA copy number gains of oncogenes EGFR and ERBB2 and copy number loss of TSG CDKN2A and SMAD4 are consistent with prior reports on HNSCC [6, 75–84]. The gene discussed is EGFR; the disease is head and neck squamous cell carcinoma.